JG Chemicals hits ₹972.9 cr in FY26 revenue, flags Dahej margin boost
Full-year PAT at ₹68.6 cr; Q4 revenue jumps 27.6% YoY. Management targets 13-14% EBITDA margins from greenfield Dahej expansion as geopolitical risks weigh on raw materials.
What's new
- FY26 revenue hit a record ₹972.9 crore; PAT at ₹68.6 crore.
- Q4 revenue grew 27.6% YoY, driven by volume and pass-through of higher input costs.
- Dahej greenfield expansion on track; management targets 13-14% EBITDA margins from the new unit.
Why it matters
Record revenue in a tough geopolitical environment shows pricing power, but the real story is the Dahej ramp-up. If margins hit the 13-14% target, JG Chemicals could structurally lift profitability above historical averages. The transcript also confirms raw cost pass-through is working, which limits earnings risk from upstream shocks.
What we're watching
- Execution timeline and cost overruns at the Dahej facility.
- Sustainability of Q4 growth pace — was it pull-forward or demand-led?
- EBITDA margin trajectory in FY27 as Dahej starts contributing.
The full read
JG Chemicals wrapped up FY26 with a record ₹972.9 crore in revenue, up 27.6% in Q4 alone, as it passed through higher raw material costs amid geopolitical tensions. PAT came in at ₹68.6 crore. The headline number is the revenue milestone, but the strategic prize is the Dahej greenfield expansion, where management expects 13-14% EBITDA margins — a step change from corporate averages. The transcript, released as an earnings call summary, offers no new shock; it confirms what the prior concall hinted: cost pass-through is working, demand is intact, and the company is spending its way into higher margins. The open question is whether Q4's velocity can hold. For now, the narrative is one of execution credibility, not just volume growth.